Extracellular Matrix (ECM) Market, By Product (Extracellular Matrix Kits, Decellularized ECM, ECM Hydrogels, ECM Scaffolds and Others), By Component, By Matrix Type, By Source, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6281
|
Published Date
October 2026
|
Pages
333
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Extracellular Matrix (ECM) market size was valued at US$ 40.9 Million in 2025, expanding at a CAGR of 8.2% from 2026 to 2033.
Extracellular matrix (ECM) refers to the complex structure of proteins and carbohydrates that surrounds the cells within the tissues. The structure of ECM is made up of structural proteins such as collagen and elastin, as well as glycoproteins, proteoglycans, and enzymes. The extracellular matrix serves as a source of support and maintains the integrity of the tissue as well as regulating various cellular processes such as proliferation, motility, and differentiation. Extracellular matrix facilitates cellular communication and plays an essential role in healing and tissue repair. The malfunctioning of the extracellular matrix causes problems such as fibrosis and cancer. Hence, extracellular matrix is a significant component of the maintenance of the tissue.
Extracellular Matrix (ECM) Market- Market Dynamics
Rising Adoption of Regenerative Medicine to Drive Market Growth
The rising adoption of regenerative medicine increases the demand for extracellular matrix (ECM) products that repair and regenerate tissues to facilitate healing processes. As such, healthcare professionals are now able to repair tissues, regenerate tissues, and improve the healing process, among other benefits through the use of ECM products in the fields of wound healing and tissue engineering, among others. In April 2025, as per the Market, NIH Gov report, the stem cell market size globally is estimated to be worth US$297 million and is expected to grow at a CAGR of 16.8% up to 2027 due to rising demand for regenerative medicine, increased funding for research, and successful clinical trials.
Also, the number of companies providing regenerative medicine services has grown from 772 to more than 1,550. Also, more than 8,000 stem cell product clinical trials have been undertaken all around the world. Therefore, the uptake of regenerative medicine has increased because of its expensive treatment and regulatory challenges.
Extracellular Matrix (ECM) Market- Segmentation Analysis:
The Global Extracellular Matrix (ECM) market is segmented on the basis of Product, Component, Matrix Type, Source, Application, End User, and Region.
As a product, hydrogels hold a significant share in the Extracellular Matrix (ECM) market since the hydrogel is biocompatible and can be tuned to control cell growth and tissue repair. For example, in August 2026, according to the NIH Gov, published in Molecular Biomedicine, hydrogels are under investigation for emerging medical applications, primarily because of their biocompatibility and modifiability. The report shows that many products involving the hydrogel are being approved by the United States FDA. These products have been used to design drug carriers, tissue repair, and diagnostic devices and tissues to carry out clinical studies. In addition, the report shows that hydrogels are currently being used in tissue engineering and regenerative medicine to heal wounds and musculoskeletal tissue repair. These advancements demonstrate the growing potential of hydrogels in medical applications.
Extracellular Matrix (ECM) Market- Geographical Insights
North America’s Extracellular Matrix (ECM) market is propelled due to advancement in regenerative medicine as well as more use of ECMs for reconstructive surgeries and wound care. For instance, in January 2026, according to the American Society of Plastic Surgeons Org., there will be increasing usage of innovative technologies in non-invasive procedures in the U.S. plastic surgery industry in January 2026. Ultrasound, laser, radio frequency (RF), and Morpheus 8 are the key innovations mentioned in the report. The Morpheus 8 is the combination of RF and microneedling technologies. As per the report, quantum technology can retract the soft tissues by 30% to 40% with the help of RF energy at the subcutaneous level. Such innovations are anticipated to fuel the U.S. treatments involving skin tightening and body contouring procedures.
China Extracellular Matrix (ECM) Market - Country Insights
China’s Extracellular Matrix (ECM) market is growing because of the improvements made in the field of regenerative medicine, biomaterial engineering, and tissue repair research. In December 2025, according to AIP Org Publishing’s AIP Advances, the number of publications increased to 2553 papers with 62878 citations and an h-index of 99. In addition, China holds the first place among other nations in the sphere with 714 documents published, whereas the US published 612 documents and India 212. The paper reveals the fact that the current advancements in tissue repair research include wound healing, tissue engineering, bioactive wound dressing, spinal cord injury treatment, and injectable hydrogels. Thus, China is working on research and development in the area of biomaterials.
Extracellular Matrix (ECM) Market- Competitive Landscape:
The Extracellular Matrix (ECM) market across the globe is boosted by developments in regenerative biomaterials, tissue engineering, and decellularized scaffolds for the repair of tissues and wound healing applications. The key market players of the extracellular matrix market invest heavily in R&D activities for their products and biomaterials used for tissue engineering. In April 2026, for example, Integra LifeSciences announced real-world evidence (RWE) for their PriMatrix® Dermal Scaffold composed of fetal bovine dermis used in wound care treatment. It has been stated that the scaffold assists clinicians in managing different types of wounds and serves as an indication of the effectiveness of their ECM-based range of products. Such advancements and innovations are believed to drive the growth of the extracellular matrix market.
Recent Developments:
- In May 2026, FUJIFILM Biosciences and NextCell Pharma introduced their commercial platform, where NextCell\'s Cord research-use-only stromal cells are used together with the PRIME-XV cell culture media from FUJIFILM to promote cell research and regenerative medicine-related research.
- In May 2025, Merck KGaA introduced the Pellicon® Capsule for viral gene therapy, which is single-use filtration technology for cell and gene therapy manufacturing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- Corning Incorporated
- Baxter International Inc.
- Integra LifeSciences
- FUJIFILM Holdings Corporation
- Merck KGaA
- Advanced BioMatrix
- REPROCELL Inc.
- BioLamina AB
- Tissue Regenix Group plc
- Smith & Nephew plc
- AMSBIO
- Mimetas
- CellSystems
- Bio-Techne Corporation
- AROA Biosurgery
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Extracellular Matrix Kits
- Decellularized ECM
- ECM Hydrogels
- ECM Scaffolds
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Glycoproteins
- Proteoglycans
- Fibrous Proteins
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY MATRIX TYPE- MARKET ANALYSIS, 2020 - 2033
- Basement Membrane
- Interstitial Matrix
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY SOURCE- MARKET ANALYSIS, 2020 - 2033
- Animal-Derived ECM
- Synthetic ECM
- Human-Derived ECM
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Regenerative Medicine
- Tissue Engineering
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Extracellular Matrix (ECM) Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Extracellular Matrix (ECM) Key Market Trends
3.1. Extracellular Matrix (ECM) Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Extracellular Matrix (ECM) Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Extracellular Matrix (ECM) Market Opportunities
3.4. Extracellular Matrix (ECM) Market Future Trends
4. Extracellular Matrix (ECM) Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Extracellular Matrix (ECM) Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Extracellular Matrix (ECM) Market Landscape
6.1. Extracellular Matrix (ECM) Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Extracellular Matrix (ECM) Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Extracellular Matrix Kits
7.1.3. Decellularized ECM
7.1.4. ECM Hydrogels
7.1.5. ECM Scaffolds
7.1.6. Others
8. Extracellular Matrix (ECM) Market – By Component
8.1. Overview
8.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
8.1.2. Glycoproteins
8.1.3. Proteoglycans
8.1.4. Fibrous Proteins
8.1.5. Others
9. Extracellular Matrix (ECM) Market – By Matrix Type
9.1. Overview
9.1.1. Segment Share Analysis, By Matrix Type, 2025 & 2033 (%)
9.1.2. Basement Membrane
9.1.3. Interstitial Matrix
10. Extracellular Matrix (ECM) Market – By Source
10.1. Overview
10.1.1. Segment Share Analysis, By Source, 2025 & 2033 (%)
10.1.2. Animal-Derived ECM
10.1.3. Synthetic ECM
10.1.4. Human-Derived ECM
11. Extracellular Matrix (ECM) Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
11.1.2. Regenerative Medicine
11.1.3. Tissue Engineering
11.1.4. Other Applications
12. Extracellular Matrix (ECM) Market – By End User
12.1. Overview
12.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
12.1.2. Biopharmaceutical Companies
12.1.3. Contract Research Organizations (CROs)
12.1.4. Academic and Research Institutes
12.1.5. Others
13. Extracellular Matrix (ECM) Market – By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
13.2. North America
13.2.1. Overview
13.2.2. Extracellular Matrix (ECM) Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.2.5. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
13.2.6. North America Market Size and Forecast, By Matrix Type, 2020 - 2033 (US$ Million)
13.2.7. North America Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.10. U.S.
13.2.11. Canada
13.3. Europe
13.3.1. Overview
13.3.2. Extracellular Matrix (ECM) Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Matrix Type, 2020 - 2033 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.10. Germany
13.3.11. UK
13.3.12. France
13.3.13. Italy
13.3.14. Spain
13.3.15. The Netherlands
13.3.16. Sweden
13.3.17. Russia
13.3.18. Poland
13.3.19. Denmark
13.3.20. Rest of Europe
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Extracellular Matrix (ECM) Key Manufacturers in Asia Pacific
13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.4.5. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
13.4.6. APAC Market Size and Forecast, By Matrix Type, 2020 - 2033 (US$ Million)
13.4.7. APAC Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.4.9. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.10. China
13.4.11. India
13.4.12. Japan
13.4.13. South Korea
13.4.14. Australia
13.4.15. Indonesia
13.4.16. Thailand
13.4.17. Philippines
13.4.18. Taiwan
13.4.19. Vietnam
13.4.20. Rest of APAC
13.5. Latin America (LATAM)
13.5.1. Overview
13.5.2. Extracellular Matrix (ECM) Key Manufacturers in Latin America
13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.5.5. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
13.5.6. LATAM Market Size and Forecast, By Matrix Type, 2020 - 2033 (US$ Million)
13.5.7. LATAM Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.5.9. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.10. Brazil
13.5.11. Mexico
13.5.12. Argentina
13.5.13. Colombia
13.5.14. Rest of LATAM
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Extracellular Matrix (ECM) Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Matrix Type, 2020 - 2033 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.10. Saudi Arabia
13.6.11. UAE
13.6.12. Israel
13.6.13. Turkey
13.6.14. Algeria
13.6.15. Egypt
13.6.16. Iran
13.6.17. Qatar
13.6.18. Rest of MEA
14. Key Vendor Analysis- Extracellular Matrix (ECM) Industry
14.1. Competitive Benchmarking
14.1.1. Competitive Dashboard
14.1.2. Competitive Positioning
14.2. Company Profiles
14.2.1. Thermo Fisher Scientific
14.2.2. Corning Incorporated
14.2.3. Baxter International Inc.
14.2.4. Integra LifeSciences
14.2.5. FUJIFILM Holdings Corporation
14.2.6. Merck KGaA
14.2.7. Advanced BioMatrix
14.2.8. REPROCELL Inc.
14.2.9. BioLamina AB
14.2.10. Tissue Regenix Group plc
14.2.11. Smith & Nephew plc
14.2.12. AMSBIO
14.2.13. Mimetas
14.2.14. CellSystems
14.2.15. Bio-Techne Corporation
14.2.16. AROA Biosurgery
14.2.17. Others
15. 360 Degree AnalystView
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- Corning Incorporated
- Baxter International Inc.
- Integra LifeSciences
- FUJIFILM Holdings Corporation
- Merck KGaA
- Advanced BioMatrix
- REPROCELL Inc.
- BioLamina AB
- Tissue Regenix Group plc
- Smith & Nephew plc
- AMSBIO
- Mimetas
- CellSystems
- Bio-Techne Corporation
- AROA Biosurgery
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Extracellular Matrix Kits
- Decellularized ECM
- ECM Hydrogels
- ECM Scaffolds
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Glycoproteins
- Proteoglycans
- Fibrous Proteins
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY MATRIX TYPE- MARKET ANALYSIS, 2020 - 2033
- Basement Membrane
- Interstitial Matrix
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY SOURCE- MARKET ANALYSIS, 2020 - 2033
- Animal-Derived ECM
- Synthetic ECM
- Human-Derived ECM
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Regenerative Medicine
- Tissue Engineering
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
GLOBAL EXTRACELLULAR MATRIX (ECM) MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
